CoChat
Sign Up
Cited by 27Bone health and treatmentsParathyroid Disorders and TreatmentsBone health and osteoporosis research

Treatment of hypercalcaemia associated with malignancy.

Open access
Wilkinson, R·1984·BMJ
DOI 10.1136/bmj.288.6420.812
Open this paper in CoChat — free accountOpen PDF

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.288.6420.812

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In hypercalcemic cancer patients treated clinically with calcitonin, the inhibitory effect on bone resorption was lost after a few days, later called the escape phenomenon.

    “Early studies have demonstrated that when calcitonin was used clinically to inhibit bone resorption in hypercalcemic cancer patients, the effects of calcitonin were lost after a few days, an effect later termed the “escape phenomenon” (158, 219).”

    From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [219]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 15

  1. [1]1. Henry RL, Mellis CM, Benjamin B. Pseudomembranous croup. Arch Dis Child 1983;58:180-3.
  2. [2]2. Welch DB, Price DG. Acute epiglottitis and severe croup. Experience in two English regions. Anaesthesia 1983;38:754-9.
  3. [3]3. Philpott-Howard J, Williams JD. Increase in antibiotic resistance in Haemophilus influenzae in the United Kingdom since 1977: report of study group. Br Medj7 1982;284:1597-9.
  4. [4]4. Phelan PD, Mullins GC, Laundau LI, Duncan AW. The period of nasotracheal intubation in acute epiglottitis. Anaesth Intenisive Care 1980;8 :402-3.
  5. [5]5. Henry R. Moist air in the treatment of laryngotracheitis. Arch Dis Child 1983 ;58 :577.
  6. [6]6. Fogel JM, Berg IJ, Gerber MA, Sherter CB. Racemic epinephrine in the treatment of croup: nebulization alone versus nebulization with inter- mittent positive pressure breathing. 7 Pediatr 1982;101:1028-31.
  7. [7]7. Lenney W, Milner AD. Treatment of acute viral croup. Arch Dis Child 1978 ;53 :704-6.
  8. [8]8. Koren G, Frand M, Barzilay Z, MacLeod SM. Corticosteroid treatment of laryngotracheitis v spasmodic croup in children. Amn 7 Dis Child 1983 ;137 :941-4.
  9. [9]9. 4Zach M, Erben A, Olinsky A. Croup, recurrent croup, allergy, and airways hyper-reactivity. Arch Dis Child 1981 ;56:336-41. QJ7 Med 1980;49:405-18.
  10. [10]10. Kanis JA, Cundy T, Heynen G, Russell RGG. The pathophysiology of hypercalcaemia. Metab Bone Dis Relat Res 1980;2:151-9.
  11. [13]13. Hosking DJ. Disequilibrium hvpercalcaemia. Br Med]7 1983;286:326-7.
  12. [14]14. Coombes RC, Ward MK, Greenberg PB, et al. Calcium metabolism in cancer. Cancer 1976;38:2111-20.
  13. [19]19. Hosking DJ. Treatment of severe hypercalcaemia with calcitonin. Metab Bone Dis Relat Res 1980;2:207-12.
  14. [21]21. Brenner DE, Harvey HA, Lipton A, DeMers L. A study of prostaglandin E2 parathormone, and response to indomethacin in patients with hyper- calcemia of malignancy. Cancer 1982;49:556-61.
  15. [23]23. Perlia CP, Gubisch NJ, Wolter J, Edelberg D, Dederick MM, Taylor SG. Mithramycin treatment of hypercalcemia. Cancer 1970;25:389-94.

Cited by

Sorted by citations

Related

Authors
Wilkinson, R.
Corresponding author
Wilkinson, R
Venue
BMJ
Publisher
BMJ
Published
1984-03-17
Volume
288
Issue
6420
Pages
812-813
ISSN
  • 0007-1447 (ISSN-L)
  • 1468-5833
DOI
10.1136/bmj.288.6420.812
OpenAlex
W2046456344
Semantic Scholar
7081f69fc54695fdb265ca9ccb5987151affe939
Cited by
27
References
23
Citations by year
2021: 1 · 2020: 1 · 2018: 1
FWCI
1.57
Type
journal article
Language
en
Open access
Licence
www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)
Locations
  • BMJ (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed (publishedVersion)
  • HighWire Press Open Archive (submittedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Bone health and treatments
  • Health Sciences › Medicine › Nephrology › Parathyroid Disorders and Treatments
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords
hypercalcemia, cancer
MeSH terms
Bone Resorption, Humans, Hypercalcemia, Neoplasms

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review